We welcome all to the 38th Annual Meeting of the European Musculo-Skeletal Oncology Society and the 26th EMSOS Nurse and Allied Professions Group Meeting in our beautiful town of Estoril.
The meeting will open with a first full day, dedicated to residents, young researchers and doctors initiating in the field of Musculo-Skeletal Oncology, in our traditional Training Day.
Both the Training Day and the main meeting will focus on this year central theme: Multidisciplinary. Our goal is to explore the multidisciplinary management of patients from diagnosis to treatment, including the role of new technologies and advances in translational research.
This meeting offers EMSOS members and non-members, alike a unique opportunity to discuss and engage with the latest developments in our field, through crossfire sessions, case discussions between different centres, and efforts to build consensus among participants.
Portugal has a long tradition in academic education, alongside with an amazing and unique hospitality. We are confident that our time in Estoril will make for an unforgettable meeting and lasting memories.
Join us for an enriching opportunity to enhance your expertise in the field.
President of the Congress
EMSOS President
EMSOS Secretary General
EMSOS Past President
The EMSOS Scientific Committee invites all participants wishing to contribute to the scientific program, to submit abstracts for presentation until January 15, 2026.
This is an opportunity to share your research with international colleagues.
Days
Hours
Minutes
Seconds
José Casanova
Preliminary Scientific Program
15, 16 & 17 AprilKeynote Speaker
Imaging (XR; CT; MRI)
Intervention Radiology - When?
Nuclear Medicine
Keynote Speaker
Concepts
Surgical vs Needle Guided Biopsy
Keynote Speaker
Whoops Lesions
Surgical Treatment of Benign Soft Tissue Tumors
Surgical Treatment of Benign Bone Tumors
Keynote Speaker
Bone Sarcomas
Soft Tissue
Keynote Speaker
Pre-op vs Post Operative
Brachytherapy
Keynote Speaker
Bone Tumors
Soft Tissue Tumors
Problems in Children
Plastic Surgery - When?
Surgical Treatment
Multidisciplinary Management
Keynote Speaker
Complications
Rehabilitation
Follow-up Protocols
AI in education and academics
Participation of different centers.
Location on site with viewing of the Best 40 Posters
MODERN IMAGING TECHNIQUES FOR SURGICAL PLANING IN BONE SARCOMAS
Radiologist, Orthopedic surgeon, Nuclear medicine
Avances in MRI, PET and AI assisted 3D planning for tumor delineation, resecability and limb-sparing surgery.
CROSS-FIRE
Advanced imaging techniques (MRI, PET, AI) should replace conventional imaging as the standard for bone tumor surgical planning.
Different centers experience or 4 oral presentations about the topic.
DISCUSSION
FROM DIAGNOSIS TO THERAPY: INTEGRATION MOLECULAR PATHOLOGY IN CLINICAL DECISION MAKING
Pathologist, Molecular Biologis, Oncologist, Orthopedic surgeon
How next-generation sequencing and fusion gene detection guide classification and trageted Therapies.
CROSS-FIRE
Universal testing vs. Selective use.
Different centers experience or 4 oral presentations about the topic.
DISCUSSION
THE ROLE OF NEOADJUVANT THERAPY IN HIGH-RISK SOFT TISSUE SARCOMA: WHAT'S THE BEST MANAGEMENT
Oncologist, pathologist, radiation oncologist, Orthopedic surgeon
Discuss evidence and controversies around chemo- and radiotherapy before surgery; evaluate histologic response and impact on margins.
CROSS-FIRE
Neoadjuvant chemotherapy and/or radiotherapy should be standard for all high-risk soft tissue sarcomas.
Teams can argue for universal use vs. selective/individualized approaches and the use of a prediction model.
Different centers experience or 4 oral presentations about the topic.
DISCUSSION
MANAGING RECURRENCE: WHEN TO RE-OPERATE, RE-IRRADIATE, OR SWITCH STRATEGY
Orthopedic surgeon, radiation oncologist, oncologist
Multimodal approaches to local and systemic recurrence.
CROSS-FIRE
Aggressive local treatment is justified for most sarcoma recurrences.
Argue for vs. against re-operation or re-irradiation in recurrent disease.
Different centers experience or 4 oral presentations about the topic.
DISCUSSION
RADIOTHERAPY IN SARCOMA: INDICATIONS, TECHNIQUES AND TIMING
Radiation oncologist, Orthopedic surgeon, oncologist
IMRT, proton therapy, neoadjuvant vs. adjuvant strategies.
CROSS-FIRE
Neoadjuvant radiotherapy should be preferred over adjuvant radiotherapy in sarcoma management. & Proton beam radiotherapy should be preferred over standard radiotherapy in sarcoma management.
One team argues for neoadjuvant or Proton as standard, the other for adjuvant or standard and discuss options in individualized choice.
Different centers experience or 4 oral presentations about the topic.
DISCUSSION
HOW MUCH MARGIN IS ENOUGH? RETHINKING RESECTION MARGINS
Pathologist, Radiation oncologist, Orthopedic surgeon
Multidisciplinary discussion on margins in STS and bone sarcoma, implications for adjuvant treatment.
CROSS-FIRE
Current margin standards in sarcoma surgery are too conservative and should be reduced.
Argue for smaller margins vs. maintaining/expanding current margins.
Different centers experience or 4 oral presentations about the topic.
DISCUSSION
TUMORS OF THE AXIAL SKELETON - SPINE & PELVIS
Orthopedic surgeon, Oncologist, Radioncologist
Different treatment options. Indications.
DEBATE
Complications and implications in the oncology treatment.
Different centers experience or 4 oral presentations about the topic.
DISCUSSION
SARCOMA BOARDS IN PRACTICE
Moderator + Full interdisciplinary panel (Live demo)
DEBATE
Is the benefit proven and worth the logistical challenges?
DISCUSSION
COMPLEX RECONSTRUCTIONS AFTER BONE TUMOR RESECTION
Orthopedic surgeon, Plastic surgeon, Physiotherapist
Megaprostheses, biological reconstruction, complications, and rehabilitation outcomes.
Megaprosthetic reconstruction should be preferred over biological options in most cases.
DEBATE
Prosthetic vs. biological reconstruction; earlier weight bearing, long term outcome, functional outcomes, complications.
Different centers experience or 4 oral presentations about the topic.
DISCUSSION
PERIPROSTHETIC INFECTION
Orthopedic surgeon; Infectiologist
The choice of antibiotic treatment in a infectiologist context.
DEBATE
DAIR and indications; substitution in two times; complex reconstructions.
Different centers experience or 4 oral presentations about the topic.
DISCUSSION
BONE SARCOMA IN CHILDREN AND ADULTS: BRIDGING THE AGE DIVIDED
Oncologist, Surgeon (Pediatric and Adult)
Differences in biology, treatment approach, outcomes - what can we learn from each other?
Pediatric treatment protocols should be applied to young adults with bone sarcoma.
DEBATE
Standardizing vs. age-specific approaches.
Different centers experience or 4 oral presentations about the topic.
DISCUSSION
Pelvic Sarcoma Surgery - Some lessons from in 20 years
NAVIGATION & NEW TECHNOLOGIES
Orthopedic surgeon, Engeneer
CROSS-FIRE
Navigation or conventional surgery - Benefices and risks - Where; When and how?
Robotics; Augmented reality and virtual reality; AI; 3D Printing - Where; When and how?
Teams wil discuss the introdution of these new techniques in orthopedic oncology surgery.
Different centers experience or 4 oral presentations about the topic.
DISCUSSION
CHODROSARCOMA: NEW TREATMENT STRATEGIES
Pathologist, Orthopedic surgeon, Oncologist, Radiologist
How to approach Grade 1–3, dedifferentiated and mesenchymal.
CROSS-FIRE
Surgery alone is sufficient for all grades of chondrosarcoma.
Debate for/against systemic therapy or adjunctive options in higher grades.
Different centers experience or 4 oral presentations about the topic.
DISCUSSION
AI ETHICS AND LAW
PATIENT VOICE IN SARCOMA CARE
SPAGN, Oncologist, Orthopedic/span>
Patient advocacy groups should have a formal role in treatment decision-making.
One side argues for integrating advocacy in decisions, the other for clinician-led choices only.
A wide range of sponsorship and exhibition opportunities are available, designed to meet different objectives — from brand exposure to direct engagement with participants. Our Secretariat will be pleased to help you identify the most suitable package to maximize your company’s impact.
We look forward to welcoming you as a valued partner of the EMSOS 2026.
VENUE
Estoril Congress Center
Located in the heart of the iconic Estoril Coast, just 25 minutes from Lisbon, the Estoril Congress Center (ECC) is one of Portugal’s leading venues for business and cultural events